Top Medical News

Ibrutinib/Rituximab Combo May Be an Effective Chemo-Free Therapy for Older Patients With MCL

January 16th 2022

Ibrutinib plus rituximab is effective, easy to administer, and removes the need for chemotherapy in older patients, say experts.

The Value of Nurse Mentorship in Oncology

January 15th 2022

In this episode of “The Vitals,” 2 veteran oncology nurses discuss the value of mentorship—particularly for novice nurses.

Patients With HER2+ Metastatic Breast Cancer Experience Consistent PFS Benefit With Trastuzumab Deruxtecan

January 14th 2022

An expert discusses the implications of a subgroup analysis of the DESTINY-BREAST03 trial, which highlighted the efficacy of trastuzumab deruxtecan in HER2-positive metastatic breast cancer.

Oral Decitabine and Cedazuridine Holds Potential to Reduce Clinic Visits, Infusion Time for Patients With Lower-Risk MDS

January 14th 2022

Oral decitabine, an oral fixed-dose of combination decitabine and CDA inhibitor cedazuridine, is an FDA-approved therapy for patients with lower-risk myelodysplastic syndromes.

New Program Helps Patients Recover Sexual Lives Following Cancer Treatment

January 13th 2022

Besides education and emotional support, the newly launched program offers personalized services including surgical interventions, hormone replacement therapy, and penile low-intensity shockwave therapy, to help patients heal from their cancer treatments.


Most Recent